<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Syst Biol</journal-id><journal-id journal-id-type="iso-abbrev">BMC Syst Biol</journal-id><journal-title-group><journal-title>BMC Systems Biology</journal-title></journal-title-group><issn pub-type="epub">1752-0509</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25628036</article-id><article-id pub-id-type="pmc">4312443</article-id><article-id pub-id-type="publisher-id">143</article-id><article-id pub-id-type="doi">10.1186/s12918-015-0143-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Positive regulation of Rho GTPase activity by RhoGDIs as a result of their direct interaction with GAPs</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ota</surname><given-names>Takahide</given-names></name><address><email>takahide@kanazawa-med.ac.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Maeda</surname><given-names>Masayo</given-names></name><address><email>nellie@kanazawa-med.ac.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Okamoto</surname><given-names>Mayumi</given-names></name><address><email>q231002cg@pu-hiroshima.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Tatsuka</surname><given-names>Masaaki</given-names></name><address><email>tatsuka@pu-hiroshima.ac.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><aff id="Aff1"><label/>Division of Tumor Biology, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa 920-0293 Japan </aff><aff id="Aff2"><label/>Department of Chemistry, Kanazawa Medical University, Uchinada, Ishikawa 920-0293 Japan </aff><aff id="Aff3"><label/>Department of Life Sciences, Life and Environmental Sciences, Prefectural University of Hiroshima, Nanatsuka, Shoubara, Hiroshima 727-0023 Japan </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>28</day><month>1</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>9</volume><elocation-id>3</elocation-id><history><date date-type="received"><day>6</day><month>12</month><year>2013</year></date><date date-type="accepted"><day>13</day><month>1</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Ota et al.; licensee BioMed Central. 2015</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>Rho GTPases function as molecular switches in many different signaling pathways and control a wide range of cellular processes. Rho GDP-dissociation inhibitors (RhoGDIs) regulate Rho GTPase signaling and can function as both negative and positive regulators. The role of RhoGDIs as negative regulators of Rho GTPase signaling has been extensively investigated; however, little is known about how RhoGDIs act as positive regulators. Furthermore, it is unclear how this opposing role of GDIs influences the Rho GTPase cycle. We constructed ordinary differential equation models of the Rho GTPase cycle in which RhoGDIs inhibit the regulatory activities of guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) by interacting with them directly as well as by sequestering the Rho GTPases. Using this model, we analyzed the role of RhoGDIs in Rho GTPase signaling.</p></sec><sec><title>Results</title><p>The model constructed in this study showed that the functions of GEFs and GAPs are integrated into Rho GTPase signaling through the interactions of these regulators with GDIs, and that the negative role of GDIs is to suppress the overall Rho activity by inhibiting GEFs. Furthermore, the positive role of GDIs is to sustain Rho activation by inhibiting GAPs under certain conditions. The interconversion between transient and sustained Rho activation occurs mainly through changes in the affinities of GDIs to GAPs and the concentrations of GAPs.</p></sec><sec><title>Conclusions</title><p>RhoGDIs positively regulate Rho GTPase signaling primarily by interacting with GAPs and may participate in the switching between transient and sustained signals of the Rho GTPases. These findings enhance our understanding of the physiological roles of RhoGDIs and Rho GTPase signaling.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1186/s12918-015-0143-5) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>RhoGDI</kwd><kwd>Rho GTPases</kwd><kwd>Ordinary differential equation</kwd><kwd>GAPs</kwd><kwd>GEFs</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Background</title><p>Rho family GTPases are members of the Ras GTPase superfamily and act as molecular switches in numerous signaling pathways that control a variety of cellular processes, including actin cytoskeletal organization, microtubule dynamics, vesicle trafficking, cell cycle progression, and cell polarization [<xref ref-type="bibr" rid="CR1">1</xref>]. Most Rho GTPases cycle between active GTP-bound and inactive GDP-bound states. There are three classes of regulators of Rho GTPases, namely, guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and GDP-dissociation inhibitors (GDIs).</p><p>GEFs activate GTPases by promoting the exchange of GDP for GTP. GAPs inactivate GTPases by stimulating their intrinsic GTP-hydrolyzing activity. GDIs are known to regulate only members of the Rho and Rab families and not other families of the Ras superfamily, although a GDI-like protein for Ras GTPases has been reported [<xref ref-type="bibr" rid="CR2">2</xref>]. Unlike GEFs and GAPs, GDIs play several roles in the regulation of the Rho family GTPases [<xref ref-type="bibr" rid="CR3">3</xref>-<xref ref-type="bibr" rid="CR6">6</xref>]. First, GDIs bind GDP-bound GTPases and inhibit the dissociation of GDP from GTPases, thereby preventing the promotion of GDP/GTP exchange by GEFs and maintaining the GTPases in an inactive state [<xref ref-type="bibr" rid="CR7">7</xref>]. Second, although the binding affinity of GDIs to GTP-bound GTPases remains controversial [<xref ref-type="bibr" rid="CR8">8</xref>-<xref ref-type="bibr" rid="CR15">15</xref>], it is possible that GDIs bind GTP-bound GTPases and inhibit both intrinsic and GAP-promoted GTP hydrolyzing activity [<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref>], thereby maintaining GTPases in an active state. Third, GDIs mediate the cycling of GTPases between cytosolic and target sites [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p>GDIs for the Rho family GTPases can therefore act to inhibit both the activation and inactivation of GTPases by interacting with GDP- and GTP-bound GTPases, respectively. This dual function of GDIs is noteworthy, and adds to our understanding of the regulatory mechanisms of the Rho GTPase cycle, because GDIs for Rab family GTPases show a marked preference for the GDP-bound form [<xref ref-type="bibr" rid="CR18">18</xref>]. Furthermore, it has also been suggested that Rho GTPases are regulated by a fine balance between GEF and GAP activities, and that the inactivation of GAP activity is a physiologically important regulatory mechanism for activating Rho GTPases [<xref ref-type="bibr" rid="CR19">19</xref>]. Nonetheless, little is known about the significance of the inhibition of GAP-promoted GTP hydrolyzing activity by GDIs in the regulation of Rho signaling. How the opposing roles of GDIs influence the Rho GTPase cycle is also unclear.</p><p>Several ordinary differential equation models and process models of the Rho GTPase cycle have been constructed and analyzed [<xref ref-type="bibr" rid="CR20">20</xref>-<xref ref-type="bibr" rid="CR24">24</xref>]. In these models, GDIs inhibit the functions of GEFs and GAPs by sequestering GDP-bound and GTP-bound GTPases, respectively. However, the actual mechanisms involved in GDI inhibition of GEF and GAP activity are not fully understood. A previous report suggested that RhoGDIs can physically interact directly with both GEFs [<xref ref-type="bibr" rid="CR25">25</xref>] and GAPs [<xref ref-type="bibr" rid="CR26">26</xref>]. Based on these observations, we constructed a model of the Rho GTPase cycle in which GDIs inhibit the activities of GEFs and GAPs not only by sequestering GTPases, but also by direct physical interaction.</p><p>Using this model, we showed that the functions of GEFs and GAPs are integrated into Rho GTPase signaling through the interactions of these regulators with GDIs and that the negative role of GDIs is to suppress the overall Rho activity by inhibiting GEFs. Additionally, the positive role of GDIs is to sustain Rho activation by inhibiting GAPs. These observations illustrate the more detailed roles RhoGDIs and further enhance our understanding of the physiological functions of Rho GTPase signaling.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Interaction of GDI with GAP sustains Rho activation</title><p>A Rho GTPase switch can be regulated by three classes of regulators: GEFs, GAPs, and GDIs. In the canonical model of the Rho GTPase cycle (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A, left), GEFs promote GDP/GTP exchange, thereby activating Rho GTPases. In contrast, GAPs promote GTP hydrolysis, thereby inactivating Rho GTPases. GDIs sequester GDP-bound GTPases from GEFs and keep them inactive; however, GDIs can also sequester GTP-bound GTPases from GAPs and keep them active. In this model, the Rho GTPase cycle functions as a simple ON/OFF switch and Rho activation is transiently elevated upon stimulation (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A, right).<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Representation of the models of Rho GTPase cycle regulation (left) and simulations of their Rho activation dynamics (right).</bold> The activation levels of GTPases were defined as the concentration of the GTP-Rho/Effector complex. <bold>A)</bold> The canonical model of the Rho GTPase cycle in which GDIs inhibit the activities of GEFs and GAPs by sequestering GTPase. <bold>B)</bold> The GDI-integrated model of the Rho GTPase cycle in which GDIs inhibit the activities of GEFs and GAPs not only by sequestering GTPase but also by interacting with GEFs and GAPs. <bold>C)</bold> GDI/GEF interaction was removed from the GDI-integrated model. <bold>D)</bold> GDI/GAP interaction was removed from the GDI-integrated model. All parameters and reactions in the models are shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Tables S1 and S2. Reaction numbers (re#) correspond to the reaction numbers in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2.</p></caption><graphic xlink:href="12918_2015_143_Fig1_HTML" id="MO1"/></fig></p><p>The majority of Rho GTPases exist in biologically inactive cytosolic complexes with GDIs, and the dissociation of GTPases from GDIs is hypothesized to be a prerequisite for activation by GEFs. However, it has been suggested that GDI and Rho GTPase can simultaneously bind GEF or GAP and form a ternary complex (GEF/GDI/Rho GTPase or GAP/GDI/Rho GTPase) [<xref ref-type="bibr" rid="CR25">25</xref>-<xref ref-type="bibr" rid="CR27">27</xref>]. According to these observations, we constructed a model of the Rho GTPase cycle (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B, left) in which GDIs inhibit the activities of GEFs and GAPs by physically interacting with them as well as by sequestering Rho GTPases (see <xref rid="Sec8" ref-type="sec">Methods</xref>). We designated this model the &#x02018;GDI-integrated model&#x02019; because the activation dynamics and ultimate output of GEFs and GAPs are integrated by GDIs to regulate Rho activity. Rho activation is sustained for a longer period of time in this model (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B, right), compared with the canonical model (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A, right).</p><p>To clarify which interaction of GDIs with GEFs or GAPs participates in this sustained Rho activation, we further modified our GDI-integrated model. When the interaction of GDIs with GEFs was removed (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>C, left), similar Rho activation dynamics, with a two-fold increase in the overall level, were obtained (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>C, right). In contrast, when the interaction of GDIs with GAPs was removed (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>D, left), Rho activation level decreased and was not sustained (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>D, right). These results therefore suggest that GDIs sustain Rho activation through interaction with GAPs.</p></sec><sec id="Sec4"><title>Influence of free (non-GTPase-complexed) GDI levels on Rho activation dynamics</title><p>To confirm the contribution of GDIs in sustaining Rho activation, we simulated Rho activation dynamics in the presence of various cellular concentrations of free GDIs, i.e., GDIs not complexed with GTPases. Based on the literature [<xref ref-type="bibr" rid="CR28">28</xref>], we calculated the concentration of free RhoGDI&#x003b1; to be 0.7&#x000a0;&#x003bc;M (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). We used a range of concentrations of free GDIs close to this value to simulate the Rho activation dynamics. The canonical model predicted that an increase in free GDIs would simply lead to an overall decrease in Rho activation (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A). However, in our GDI-integrated model, while the increase of free GDIs also led to an overall decrease in Rho activation, this did not negate the sustained Rho activation (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>B). Unexpectedly, the presence of free GDIs sustained the Rho activation level beyond 1,800&#x000a0;min after stimulation, in contrast to the cessation observed at this time point in the absence of free GDIs (Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>C).<fig id="Fig2"><label>Figure 2</label><caption><p>
<bold>Free (non-GTPase-complexed) GDI concentration affects the prolongation of Rho activation in the GDI-integrated model.</bold> Rho activation dynamics were simulated at various concentration of free GDI. <bold>A)</bold> 600&#x000a0;min after stimulation in the canonical model. <bold>B)</bold> 600&#x000a0;min after stimulation in the GDI-integrated model. <bold>C)</bold> 1,800&#x000a0;min after stimulation in the GDI-integrated model. The activation levels of GTPases were expressed as the concentration of GTP-Rho/Effector complex.</p></caption><graphic xlink:href="12918_2015_143_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec5"><title>Influence of GDI affinity for GEF and GAP and the concentration of GEF and GAP on Rho activation dynamics</title><p>Phosphorylation affects the affinity of GDIs for various Rho GTPases [<xref ref-type="bibr" rid="CR29">29</xref>-<xref ref-type="bibr" rid="CR33">33</xref>] and affects the function of GEFs [<xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref>] and GAPs [<xref ref-type="bibr" rid="CR36">36</xref>-<xref ref-type="bibr" rid="CR38">38</xref>]. Therefore, phosphorylation may modify the regulation of Rho signaling by GDIs, GEFs and GAPs. To examine how the affinity of GDIs for GEFs (<italic>K</italic><sub><italic>m</italic>GEF/GDI</sub>) and GAPs (<italic>K</italic><sub><italic>m</italic>GAP/GDI</sub>) affects the ability of GDIs to sustain Rho activation, we simulated the Rho activation dynamics at 0.01, 0.1, and 1.0&#x000a0;&#x003bc;M of <italic>K</italic><sub><italic>m</italic>GEF/GDI</sub> and <italic>K</italic><sub><italic>m</italic>GAP/GDI</sub> in our model. The decrease of <italic>K</italic><sub><italic>m</italic>GEF/GDI</sub> resulted in overall decrease of Rho activation at all the tested concentrations of <italic>K</italic><sub><italic>m</italic>GAP/GDI</sub> (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A). The Rho activation was markedly sustained at 0.01 and 0.1&#x000a0;&#x003bc;M of <italic>K</italic><sub><italic>m</italic>GAP/GDI</sub> and decreasing <italic>K</italic><sub><italic>m</italic>GEF/GDI</sub> did not negate the sustained Rho activation (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A). Conversely, as the <italic>K</italic><sub><italic>m</italic>GAP/GDI</sub> value became smaller, the Rho activation was sustained to a greater degree at all <italic>K</italic><sub><italic>m</italic>GEF/GDI</sub> (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B). These results indicate that the sustained Rho activation can primarily be attributed to the interaction between GAPs and GDIs, and the higher affinity of GDIs for GAPs promotes sustained Rho activation.<fig id="Fig3"><label>Figure 3</label><caption><p>
<bold>Prolongation of Rho activation in the GDI-integrated model is dependent on</bold>
<bold><italic>K</italic></bold>
<sub><bold><italic>m</italic></bold><bold>GAP/GDI</bold></sub>
<bold>and the GAP concentration.</bold> Rho activation dynamics were simulated at various <italic>K</italic>
<sub><italic>m</italic>GEF/GDI</sub> values <bold>(A)</bold>, <italic>K</italic>
<sub><italic>m</italic>GAP/GDI</sub> values <bold>(B)</bold>, GEF concentration <bold>(C)</bold>, and GAP concentrations <bold>(D)</bold> in the GDI-integrated model. The activation levels of GTPases were expressed as the concentration of GTP-Rho/Effector complex.</p></caption><graphic xlink:href="12918_2015_143_Fig3_HTML" id="MO3"/></fig></p><p>It was also suggested that the local concentration of GEFs and GAPs defined the modes of Rho GTPase signaling [<xref ref-type="bibr" rid="CR22">22</xref>]. We examined how the concentration of GEFs and GAPs affected the ability of GDIs to sustain Rho activation. We simulated the Rho activation dynamics at 0.1, 0.3, and 0.9&#x000a0;&#x003bc;M concentrations of GEFs and GAPs in our model. The decrease of GEF concentration resulted in overall decrease of Rho activation at all of the tested GAP concentrations (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C). The sustained Rho activation was apparent only at 0.1&#x000a0;&#x003bc;M of GAP and the decrease of GEF concentration did not negate this sustained Rho activation (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>C). However, at all of the tested GEF concentrations, as the GAP concentrations became smaller, Rho activation was sustained to a higher degree, and increasing GAP concentration negated this sustained Rho activation (Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>D). These results indicate that the sustained Rho activation is dependent on the concentration of GAPs, and a lower GAP concentration sustains Rho activation. Finally, we compared the Rho activation dynamics at 0.01, 0.1, and 1.0&#x000a0;&#x003bc;M <italic>K</italic><sub><italic>m</italic>GAP/GDI</sub> under various concentrations of free GDI. A decrease in the <italic>K</italic><sub><italic>m</italic>GAP/GDI</sub> value enhanced the prolongation of Rho activation regardless of free GDI concentration (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A). Surprisingly, at 0.01&#x000a0;&#x003bc;M <italic>K</italic><sub><italic>m</italic>GAP/GDI</sub>, Rho activation was sustained for a significant period of time, longer than 12,000&#x000a0;min (8.3&#x000a0;days), after stimulation in the presence of free GDI (Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B). However, the overall levels of Rho activation markedly decreased in association with an increase in free GDI. These results suggest that GDIs enable extremely long-term retention of the activated state of the Rho GTPases.<fig id="Fig4"><label>Figure 4</label><caption><p>
<bold>GDI enables extremely long-term retention of the activation state of Rho GTPases.</bold> Simulation of Rho activation dynamics at <italic>K</italic>
<sub><italic>m</italic>GAP/GDI</sub>&#x02009;=&#x02009;0.01, 01, and 1.0&#x000a0;&#x003bc;M in the presence of various free GDI concentrations (0&#x02013;2.4&#x000a0;&#x003bc;M) in the GDI-integrated model. <bold>A)</bold> 600&#x000a0;min after stimulation. <bold>B)</bold> 12,000&#x000a0;min after stimulation. The activation levels of GTPases were expressed as the concentration of GTP-Rho/Effector complex.</p></caption><graphic xlink:href="12918_2015_143_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec6" sec-type="discussion"><title>Discussion</title><p>It is well established that the main function of RhoGDIs is to maintain Rho GTPases in inactive soluble complexes. In many canonical models of the Rho GTPase cycle, GDIs extract GTPases from the membrane and sequester them as inactive cytosolic complexes. RhoGDIs are therefore predominantly thought to act as negative regulators; however, they inhibit both activation [<xref ref-type="bibr" rid="CR7">7</xref>] and inactivation [<xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref>] of GTPases. Little is known about how the opposing functions of GDIs influence the Rho GTPase cycle.</p><p>In the present study, we constructed a model of the Rho GTPase cycle, designated as the GDI-integrated model, in which GDIs inhibit the activities of GEFs and GAPs by interacting with them in addition to sequestering the Rho GTPases. This model indicated that GDIs sustain the activation of Rho GTPase by interacting with GAPs. Furthermore, as expected from the positive regulatory role of GDIs, (in other words, the inhibition of GAP activity by GDIs), an increase in the intracellular concentration of free GDIs enhanced the prolongation of Rho activation despite the overall decrease in the Rho activation level.</p><p>It was previously reported that the molar amount of RhoGDI&#x003b1; is roughly equal to the molar total of the RhoA, Rac1, and Cdc42 GTPases in several types of cultured cells [<xref ref-type="bibr" rid="CR28">28</xref>]. RhoGDI&#x003b2; is strongly expressed in hematopoietic cell lineages [<xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref>] and in other cell types [<xref ref-type="bibr" rid="CR41">41</xref>-<xref ref-type="bibr" rid="CR43">43</xref>], though it is not as ubiquitous as RhoGDI&#x003b1;. Specificities of RhoGDIs for Rho GTPases are largely unknown, but both RhoGDI&#x003b1; and RhoGDI&#x003b2; can associate with RhoA, Cdc42, and Rac1 in some cell types [<xref ref-type="bibr" rid="CR3">3</xref>]. Therefore, in RhoGDI&#x003b2;-expressing cells, the total amount of RhoGDI&#x003b1; and RhoGDI&#x003b2; may exceed the total amount of these Rho GTPases. In such cases, RhoGDIs may exist in a non-GTPase-complexed form in the cell and may function to sustain Rho activation for long periods.</p><p>RhoGDI&#x003b2; is implicated in cancer progression, however, reports have presented contradictory evidence as to the nature of the correlation between cancer progression and RhoGDI&#x003b2; expression level [<xref ref-type="bibr" rid="CR44">44</xref>]. We have also reported that RhoGDI&#x003b2; plays a positive [<xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref>] and negative [<xref ref-type="bibr" rid="CR47">47</xref>] role in cancer progression. Several explanations for this contradictory behavior of RhoGDI&#x003b2; have been proposed [<xref ref-type="bibr" rid="CR44">44</xref>]. Our present study suggests that RhoGDI can act both as a positive and negative regulator of GTPases, and which role RhoGDI plays may depend on its expression level. This presents at least a partial explanation for the inconsistent correlation of RhoGDI&#x003b2; with cancer progression.</p><p>It has been proposed that intracellular signals are transmitted through the dynamic activities of signaling molecules (defined as the temporal change in activity of a molecule) [<xref ref-type="bibr" rid="CR48">48</xref>]. For example, in the case of ERK (extracellular signal-regulated kinases), transient and sustained activation states have been shown to result in different cellular responses [<xref ref-type="bibr" rid="CR49">49</xref>]. It is well established that GEFs and GAPs function as positive and negative regulators of Rho GTPase cycles, respectively. We have shown that the functions of GEFs and GAPs are modulated by their interactions with GDIs, and that the interconversion between transient and sustained Rho activation occurs mainly through changes in the affinities of GDIs to GAPs and the concentrations of GAPs. The properties of GDIs and GAPs are regulated by posttranscriptional modifications [<xref ref-type="bibr" rid="CR29">29</xref>-<xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR36">36</xref>-<xref ref-type="bibr" rid="CR38">38</xref>] and the affinity between GDIs and GAPs may be altered by such modifications. Therefore, RhoGDIs and GAPs might participate in the switching between transient and sustained signals of the Rho GTPases. Although this mode seems not to be common in the regulation of Rho GTPases, certain sets of GTPases, GEFs, and GAPs may use this mode of regulation.</p><p>In the present study, we proposed a simplified model for positive regulation of Rho GTPases by GDIs. However, the model does not take into account GTPase cycling between membrane and cytosol. Cells contain membranous and cytoplasmic compartments, and typically, Rho GTPases function within the membranous compartments. It has been shown that the efficient cycling between inactive and active states of GTPases can occur entirely within protein complexes assembled on membrane surfaces [<xref ref-type="bibr" rid="CR22">22</xref>]. RhoGDIs mediate the membrane-cytoplasmic shuttling of GTPases, and likely can alter the concentrations of GTPases and their RhoGDI-associated regulators at target sites in cells. Therefore, it is necessary to take into account the shuttling processes in developing a truly comprehensive model. Membrane-cytoplasmic shuttling has been considered in a simulation of the distribution of activated Cdc42 during the early phase of yeast bud formation [<xref ref-type="bibr" rid="CR23">23</xref>]. Additionally, a modeling framework describing Rac cycling between membrane and cytosol has been reported [<xref ref-type="bibr" rid="CR21">21</xref>]. Because our model for the Rho GTPase switch can be regarded as a basal signaling module, these studies that have taken into account the Rho GTPase shuttling processes should be incorporated into our model of the Rho GTPase switch for a more detailed and biologically-relevant model.</p></sec><sec id="Sec7" sec-type="conclusion"><title>Conclusions</title><p>We constructed models of the Rho GTPase cycle in which RhoGDIs inhibit the activities of GEFs and GAPs by physically interacting with them, as well as by sequestering the Rho GTPases. This model showed that the functions of GEFs and GAPs are integrated into Rho GTPase signaling through the interactions of these regulators with GDIs, and thus, the interconversion between transient and sustained Rho activation occurs by changes mainly in the affinities of GDIs to GAPs and the concentrations of GAPs. These results provide new insights into the physiological roles of Rho GTPase signaling.</p></sec><sec id="Sec8" sec-type="materials|methods"><title>Methods</title><sec id="Sec9"><title>Construction of models</title><p>The pathway diagrams of the Rho GTPase cycle and their simulation programs were described using CellDesigner (Systems Biology Institute, Tokyo, Japan) [<xref ref-type="bibr" rid="CR50">50</xref>], and were simulated by SOSLib in CellDesigner. All kinetic reactions in the pathway diagrams in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> were described by ordinary differential equations based on mass-action kinetics (reactions 1, 2, 3, 6, 7, and 8) or Michaelis&#x02013;Menten kinetics (reactions 4 and 5) [<xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR52">52</xref>].</p><p>In the canonical model (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A), we used a typical Michaelis&#x02013;Menten kinetic model to describe the promoting activities of GEFs (reaction 4 in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A and C) and GAPs (reaction 5 in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A and D) towards the Rho GTPases. GDIs inhibit the activities of GEFs and GAPs only by sequestering Rho GTPases.</p><p>The majority of Rho GTPases exist in biologically inactive cytosolic complexes with GDIs and the dissociation of GTPases from GDIs is hypothesized to be a prerequisite for activation by GEFs. However, it has been suggested that &#x003b2;PIX (GEF), Rac1, and RhoGDI&#x003b1; form a ternary complex [<xref ref-type="bibr" rid="CR27">27</xref>] and that Bcr (GAP), Rac, and RhoGDI&#x003b1; also form a ternary complex [<xref ref-type="bibr" rid="CR26">26</xref>]. Furthermore, several studies have shown that GDIs directly interact with both GEFs [<xref ref-type="bibr" rid="CR25">25</xref>] and GAPs [<xref ref-type="bibr" rid="CR26">26</xref>]. These observations suggest that GDIs and Rho GTPases can simultaneously bind GEFs or GAPs, and form ternary complexes. According to these observations, we constructed a model of the Rho GTPase cycle (Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B, left) in which GDIs inhibit the activities of GEFs and GAPs by interacting with them as well as by sequestering Rho GTPases. We used the non-competitive inhibition model of Michaelis&#x02013;Menten kinetics to describe the reactions in which GDIs inhibit the actions of GEFs (reaction 4 in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B and D) and GAPs (reaction 5 in Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B and C), because in the non-competitive inhibition model the inhibitor and substrate can simultaneously bind the enzyme. The processes of GTPase cycling between membrane and cytosol are very important for understanding Rho activation dynamics. However, in the present study we focused on the interaction of GDIs and GEFs/GAPs and address how GDIs regulate GTPase activity through these interactions. Therefore, to simplify the model we did not consider the membrane localization of Rho GTPases and their regulators in our models.</p><p>Parameters and equations in the models are listed in Tables S1 and S2 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>). The kinetic parameters and initial concentrations of molecules were determined based on previous studies [<xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR53">53</xref>-<xref ref-type="bibr" rid="CR56">56</xref>] or arbitrary values. The activation levels of GTPases were defined as the concentrations of the GTP-Rho/Effector complex. Model files are provided as .xml files (Additional files <xref rid="MOESM2" ref-type="media">2</xref> and <xref rid="MOESM3" ref-type="media">3</xref>) in the supplementary materials and can be viewed using CellDesigner [<xref ref-type="bibr" rid="CR50">50</xref>].</p></sec></sec></body><back><app-group><app id="App1"><sec id="Sec10"><title>Additional files</title><p><media position="anchor" xlink:href="12918_2015_143_MOESM1_ESM.pdf" id="MOESM1"><label>Additional file 1:</label><caption><p>
<bold>Tables S1-2.pdf.</bold>
<bold>Table S1.</bold> lists the initial concentrations of molecules. <bold>Table S2.</bold> lists the kinetic reactions, ordinary differential equations, and parameters used in the models.</p></caption></media><media position="anchor" xlink:href="12918_2015_143_MOESM2_ESM.zip" id="MOESM2"><label>Additional file 2:</label><caption><p>
<bold>Canonical model.xml.</bold> The canonical model file is provided as an .xml file and can be viewed using CellDesigner.</p></caption></media><media position="anchor" xlink:href="12918_2015_143_MOESM3_ESM.zip" id="MOESM3"><label>Additional file 3:</label><caption><p>
<bold>GDI-integrated model.xml.</bold> The GDI-integrated model file is provided as an .xml file and can be viewed using CellDesigner.</p></caption></media></p></sec></app></app-group><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>TO conceived of the project. TO, MM, MO, and MT carried out the studies. TO drafted the manuscript. All authors read and approved the final manuscript.</p></fn></fn-group><ack><p>This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (16590642 and 20591596 to TO and 13671354, 16591368, 18590706, and 20591596 to MM) and Grant for Assist KAKEN from Kanazawa Medical University (K2014-9).</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etienne-Manneville</surname><given-names>S</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name></person-group><article-title>Rho GTPases in cell biology</article-title><source>Nature</source><year>2002</year><volume>420</volume><issue>6916</issue><fpage>629</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/nature01148</pub-id><pub-id pub-id-type="pmid">12478284</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nancy</surname><given-names>V</given-names></name><name><surname>Callebaut</surname><given-names>I</given-names></name><name><surname>El Marjou</surname><given-names>A</given-names></name><name><surname>de Gunzburg</surname><given-names>J</given-names></name></person-group><article-title>The delta subunit of retinal rod cGMP phosphodiesterase regulates the membrane association of Ras and Rap GTPases</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><issue>17</issue><fpage>15076</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11786539</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DerMardirossian</surname><given-names>C</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name></person-group><article-title>GDIs: central regulatory molecules in Rho GTPase activation</article-title><source>Trends Cell Biol</source><year>2005</year><volume>15</volume><issue>7</issue><fpage>356</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2005.05.001</pub-id><pub-id pub-id-type="pmid">15921909</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dovas</surname><given-names>A</given-names></name><name><surname>Couchman</surname><given-names>JR</given-names></name></person-group><article-title>RhoGDI: multiple functions in the regulation of Rho family GTPase activities</article-title><source>Biochem J</source><year>2005</year><volume>390</volume><issue>Pt 1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16083425</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dransart</surname><given-names>E</given-names></name><name><surname>Olofsson</surname><given-names>B</given-names></name><name><surname>Cherfils</surname><given-names>J</given-names></name></person-group><article-title>RhoGDIs revisited: novel roles in Rho regulation</article-title><source>Traffic</source><year>2005</year><volume>6</volume><issue>11</issue><fpage>957</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2005.00335.x</pub-id><pub-id pub-id-type="pmid">16190977</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Mata</surname><given-names>R</given-names></name><name><surname>Boulter</surname><given-names>E</given-names></name><name><surname>Burridge</surname><given-names>K</given-names></name></person-group><article-title>The 'invisible hand': regulation of RHO GTPases by RHOGDIs</article-title><source>Nat Rev Mol Cell Biol</source><year>2011</year><volume>12</volume><issue>8</issue><fpage>493</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1038/nrm3153</pub-id><pub-id pub-id-type="pmid">21779026</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name></person-group><article-title>The Rho small G protein family-Rho GDI system as a temporal and spatial determinant for cytoskeletal control</article-title><source>Biochem Biophys Res Commun</source><year>1998</year><volume>245</volume><issue>3</issue><fpage>641</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1998.8253</pub-id><pub-id pub-id-type="pmid">9588168</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname><given-names>JF</given-names></name><name><surname>Hall</surname><given-names>A</given-names></name></person-group><article-title>A novel role for RhoGDI as an inhibitor of GAP proteins</article-title><source>Embo J</source><year>1993</year><volume>12</volume><issue>5</issue><fpage>1915</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">8491184</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JL</given-names></name><name><surname>Erickson</surname><given-names>JW</given-names></name><name><surname>Cerione</surname><given-names>RA</given-names></name></person-group><article-title>New insights into how the Rho guanine nucleotide dissociation inhibitor regulates the interaction of Cdc42 with membranes</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><issue>35</issue><fpage>23860</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.031815</pub-id><pub-id pub-id-type="pmid">19581296</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>G</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Masuda</surname><given-names>T</given-names></name><name><surname>Yamochi</surname><given-names>W</given-names></name><name><surname>Nonaka</surname><given-names>H</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name></person-group><article-title>Association of the Rho family small GTP-binding proteins with Rho GDP dissociation inhibitor (Rho GDI) in Saccharomyces cerevisiae</article-title><source>Oncogene</source><year>1997</year><volume>15</volume><issue>4</issue><fpage>417</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1201194</pub-id><pub-id pub-id-type="pmid">9242378</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomanbhoy</surname><given-names>TK</given-names></name><name><surname>Cerione</surname><given-names>R</given-names></name></person-group><article-title>Characterization of the interaction between RhoGDI and Cdc42Hs using fluorescence spectroscopy</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><issue>17</issue><fpage>10004</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.17.10004</pub-id><pub-id pub-id-type="pmid">8626553</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name></person-group><article-title>Consequences of weak interaction of rho GDI with the GTP-bound forms of rho p21 and rac p21</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><issue>32</issue><fpage>23959</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">8226937</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiedje</surname><given-names>C</given-names></name><name><surname>Sakwa</surname><given-names>I</given-names></name><name><surname>Just</surname><given-names>U</given-names></name><name><surname>Hofken</surname><given-names>T</given-names></name></person-group><article-title>The Rho GDI Rdi1 regulates Rho GTPases by distinct mechanisms</article-title><source>Mol Biol Cell</source><year>2008</year><volume>19</volume><issue>7</issue><fpage>2885</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1091/mbc.E07-11-1152</pub-id><pub-id pub-id-type="pmid">18417612</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tnimov</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>Z</given-names></name><name><surname>Gambin</surname><given-names>Y</given-names></name><name><surname>Nguyen</surname><given-names>UT</given-names></name><name><surname>Wu</surname><given-names>YW</given-names></name><name><surname>Abankwa</surname><given-names>D</given-names></name><etal/></person-group><article-title>Quantitative analysis of prenylated RhoA interaction with its chaperone, RhoGDI</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><issue>32</issue><fpage>26549</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.371294</pub-id><pub-id pub-id-type="pmid">22628549</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueda</surname><given-names>T</given-names></name><name><surname>Kikuchi</surname><given-names>A</given-names></name><name><surname>Ohga</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>J</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name></person-group><article-title>Purification and characterization from bovine brain cytosol of a novel regulatory protein inhibiting the dissociation of GDP from and the subsequent binding of GTP to rhoB p20, a ras p21-like GTP-binding protein</article-title><source>J Biol Chem</source><year>1990</year><volume>265</volume><issue>16</issue><fpage>9373</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">2111820</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>TH</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Knaus</surname><given-names>UG</given-names></name><name><surname>Hart</surname><given-names>MJ</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name></person-group><article-title>GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><issue>2</issue><fpage>775</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8419353</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>MJ</given-names></name><name><surname>Maru</surname><given-names>Y</given-names></name><name><surname>Leonard</surname><given-names>D</given-names></name><name><surname>Witte</surname><given-names>ON</given-names></name><name><surname>Evans</surname><given-names>T</given-names></name><name><surname>Cerione</surname><given-names>RA</given-names></name></person-group><article-title>A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs</article-title><source>Science</source><year>1992</year><volume>258</volume><issue>5083</issue><fpage>812</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1126/science.1439791</pub-id><pub-id pub-id-type="pmid">1439791</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rak</surname><given-names>A</given-names></name><name><surname>Pylypenko</surname><given-names>O</given-names></name><name><surname>Durek</surname><given-names>T</given-names></name><name><surname>Watzke</surname><given-names>A</given-names></name><name><surname>Kushnir</surname><given-names>S</given-names></name><name><surname>Brunsveld</surname><given-names>L</given-names></name><etal/></person-group><article-title>Structure of Rab GDP-dissociation inhibitor in complex with prenylated YPT1 GTPase</article-title><source>Science</source><year>2003</year><volume>302</volume><issue>5645</issue><fpage>646</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1126/science.1087761</pub-id><pub-id pub-id-type="pmid">14576435</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincent</surname><given-names>S</given-names></name><name><surname>Settleman</surname><given-names>J</given-names></name></person-group><article-title>Inhibition of RhoGAP activity is sufficient for the induction of Rho-mediated actin reorganization</article-title><source>Eur J Cell Biol</source><year>1999</year><volume>78</volume><issue>8</issue><fpage>539</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/S0171-9335(99)80019-3</pub-id><pub-id pub-id-type="pmid">10494860</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardelli</surname><given-names>L</given-names></name><name><surname>Caron</surname><given-names>E</given-names></name><name><surname>Gardner</surname><given-names>P</given-names></name><name><surname>Kahramanogullari</surname><given-names>O</given-names></name><name><surname>Phillips</surname><given-names>A</given-names></name></person-group><article-title>A Process Model of Rho GTP-binding Proteins</article-title><source>Theor Comput Sci</source><year>2009</year><volume>410</volume><issue>33&#x02013;34</issue><fpage>3166</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.tcs.2009.04.029</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falkenberg</surname><given-names>CV</given-names></name><name><surname>Loew</surname><given-names>LM</given-names></name></person-group><article-title>Computational analysis of Rho GTPase cycling</article-title><source>PLoS Comput Biol</source><year>2013</year><volume>9</volume><issue>1</issue><fpage>e1002831</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002831</pub-id><pub-id pub-id-type="pmid">23326220</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goryachev</surname><given-names>AB</given-names></name><name><surname>Pokhilko</surname><given-names>AV</given-names></name></person-group><article-title>Computational model explains high activity and rapid cycling of Rho GTPases within protein complexes</article-title><source>PLoS Comput Biol</source><year>2006</year><volume>2</volume><issue>12</issue><fpage>e172</fpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.0020172</pub-id><pub-id pub-id-type="pmid">17140284</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goryachev</surname><given-names>AB</given-names></name><name><surname>Pokhilko</surname><given-names>AV</given-names></name></person-group><article-title>Dynamics of Cdc42 network embodies a Turing-type mechanism of yeast cell polarity</article-title><source>FEBS Lett</source><year>2008</year><volume>582</volume><issue>10</issue><fpage>1437</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2008.03.029</pub-id><pub-id pub-id-type="pmid">18381072</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipshtat</surname><given-names>A</given-names></name><name><surname>Jayaraman</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>JC</given-names></name><name><surname>Iyengar</surname><given-names>R</given-names></name></person-group><article-title>Design of versatile biochemical switches that respond to amplitude, duration, and spatial cues</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><issue>3</issue><fpage>1247</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1073/pnas.0908647107</pub-id><pub-id pub-id-type="pmid">20080566</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groysman</surname><given-names>M</given-names></name><name><surname>Russek</surname><given-names>CS</given-names></name><name><surname>Katzav</surname><given-names>S</given-names></name></person-group><article-title>Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation</article-title><source>FEBS Lett</source><year>2000</year><volume>467</volume><issue>1</issue><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(00)01121-2</pub-id><pub-id pub-id-type="pmid">10664460</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kweon</surname><given-names>SM</given-names></name><name><surname>Cho</surname><given-names>YJ</given-names></name><name><surname>Minoo</surname><given-names>P</given-names></name><name><surname>Groffen</surname><given-names>J</given-names></name><name><surname>Heisterkamp</surname><given-names>N</given-names></name></person-group><article-title>Activity of the Bcr GTPase-activating domain is regulated through direct protein/protein interaction with the Rho guanine nucleotide dissociation inhibitor</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><issue>6</issue><fpage>3023</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1074/jbc.M705513200</pub-id><pub-id pub-id-type="pmid">18070886</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>EY</given-names></name><name><surname>Shim</surname><given-names>ES</given-names></name><name><surname>Lee</surname><given-names>CS</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>EG</given-names></name></person-group><article-title>Phosphorylation of RhoGDI1 by p21-activated kinase 2 mediates basic fibroblast growth factor-stimulated neurite outgrowth in PC12 cells</article-title><source>Biochem Biophys Res Commun</source><year>2009</year><volume>379</volume><issue>2</issue><fpage>384</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.12.066</pub-id><pub-id pub-id-type="pmid">19103160</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaelson</surname><given-names>D</given-names></name><name><surname>Silletti</surname><given-names>J</given-names></name><name><surname>Murphy</surname><given-names>G</given-names></name><name><surname>D'Eustachio</surname><given-names>P</given-names></name><name><surname>Rush</surname><given-names>M</given-names></name><name><surname>Philips</surname><given-names>MR</given-names></name></person-group><article-title>Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding</article-title><source>J Cell Biol</source><year>2001</year><volume>152</volume><issue>1</issue><fpage>111</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1083/jcb.152.1.111</pub-id><pub-id pub-id-type="pmid">11149925</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DerMardirossian</surname><given-names>C</given-names></name><name><surname>Rocklin</surname><given-names>G</given-names></name><name><surname>Seo</surname><given-names>J-Y</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name></person-group><article-title>Phosphorylation of RhoGDI by Src Regulates Rho GTPase Binding and Cytosol-Membrane Cycling</article-title><source>Mol Biol Cell</source><year>2006</year><volume>17</volume><issue>11</issue><fpage>4760</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1091/mbc.E06-06-0533</pub-id><pub-id pub-id-type="pmid">16943322</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DerMardirossian</surname><given-names>C</given-names></name><name><surname>Schnelzer</surname><given-names>A</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name></person-group><article-title>Phosphorylation of RhoGDI by Pak1 mediates dissociation of Rac GTPase</article-title><source>Mol Cell</source><year>2004</year><volume>15</volume><issue>1</issue><fpage>117</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.05.019</pub-id><pub-id pub-id-type="pmid">15225553</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dovas</surname><given-names>A</given-names></name><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Yoneda</surname><given-names>A</given-names></name><name><surname>Multhaupt</surname><given-names>HA</given-names></name><name><surname>Kwon</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>D</given-names></name><etal/></person-group><article-title>Serine 34 phosphorylation of rho guanine dissociation inhibitor (RhoGDI&#x003b1;) links signaling from conventional protein kinase C to RhoGTPase in cell adhesion</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><issue>30</issue><fpage>23296</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.098129</pub-id><pub-id pub-id-type="pmid">20472934</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elfenbein</surname><given-names>A</given-names></name><name><surname>Rhodes</surname><given-names>JM</given-names></name><name><surname>Meller</surname><given-names>J</given-names></name><name><surname>Schwartz</surname><given-names>MA</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name></person-group><article-title>Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKC&#x003b1; in a Rac1 activation pathway</article-title><source>J Cell Biol</source><year>2009</year><volume>186</volume><issue>1</issue><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1083/jcb.200810179</pub-id><pub-id pub-id-type="pmid">19581409</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knezevic</surname><given-names>N</given-names></name><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Timblin</surname><given-names>B</given-names></name><name><surname>Konstantoulaki</surname><given-names>M</given-names></name><name><surname>Sharma</surname><given-names>T</given-names></name><name><surname>Malik</surname><given-names>AB</given-names></name><etal/></person-group><article-title>GDI-1 phosphorylation switch at serine 96 induces RhoA activation and increased endothelial permeability</article-title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><issue>18</issue><fpage>6323</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1128/MCB.00523-07</pub-id><pub-id pub-id-type="pmid">17636025</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Rossman</surname><given-names>KL</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Ritola</surname><given-names>KD</given-names></name><name><surname>Chiang</surname><given-names>D</given-names></name><name><surname>Campbell</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Vav2 is an activator of Cdc42, Rac1, and RhoA</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><issue>14</issue><fpage>10141</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1074/jbc.275.14.10141</pub-id><pub-id pub-id-type="pmid">10744696</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuebel</surname><given-names>KE</given-names></name><name><surname>Movilla</surname><given-names>N</given-names></name><name><surname>Rosa</surname><given-names>JL</given-names></name><name><surname>Bustelo</surname><given-names>XR</given-names></name></person-group><article-title>Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2</article-title><source>EMBO J</source><year>1998</year><volume>17</volume><issue>22</issue><fpage>6608</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.22.6608</pub-id><pub-id pub-id-type="pmid">9822605</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doki</surname><given-names>N</given-names></name><name><surname>Kawashima</surname><given-names>T</given-names></name><name><surname>Nomura</surname><given-names>Y</given-names></name><name><surname>Tsuchiya</surname><given-names>A</given-names></name><name><surname>Oneyama</surname><given-names>C</given-names></name><name><surname>Akagi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Constitutive phosphorylation of a Rac GAP MgcRacGAP is implicated in v-Src-induced transformation of NIH3T3 cells</article-title><source>Cancer Sci</source><year>2009</year><volume>100</volume><issue>9</issue><fpage>1675</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1349-7006.2009.01235.x</pub-id><pub-id pub-id-type="pmid">19555392</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pullikuth</surname><given-names>AK</given-names></name><name><surname>Catling</surname><given-names>AD</given-names></name></person-group><article-title>Extracellular signal-regulated kinase promotes Rho-dependent focal adhesion formation by suppressing p190A RhoGAP</article-title><source>Mol Cell Biol</source><year>2010</year><volume>30</volume><issue>13</issue><fpage>3233</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1128/MCB.01178-09</pub-id><pub-id pub-id-type="pmid">20439493</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieillemard</surname><given-names>A</given-names></name><name><surname>Prouzet-Mauleon</surname><given-names>V</given-names></name><name><surname>Hugues</surname><given-names>M</given-names></name><name><surname>Lefebvre</surname><given-names>F</given-names></name><name><surname>Mitteau</surname><given-names>R</given-names></name><name><surname>Claverol</surname><given-names>S</given-names></name><etal/></person-group><article-title>The Saccharomyces cerevisiae RhoGAP Rgd1 is phosphorylated by the Aurora B like kinase Ipl1</article-title><source>Biochem Biophys Res Commun</source><year>2013</year><volume>433</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.02.081</pub-id><pub-id pub-id-type="pmid">23454383</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lelias</surname><given-names>JM</given-names></name><name><surname>Adra</surname><given-names>CN</given-names></name><name><surname>Wulf</surname><given-names>GM</given-names></name><name><surname>Guillemot</surname><given-names>JC</given-names></name><name><surname>Khagad</surname><given-names>M</given-names></name><name><surname>Caput</surname><given-names>D</given-names></name><etal/></person-group><article-title>cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP- binding proteins</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><issue>4</issue><fpage>1479</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.4.1479</pub-id><pub-id pub-id-type="pmid">8434008</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherle</surname><given-names>P</given-names></name><name><surname>Behrens</surname><given-names>T</given-names></name><name><surname>Staudt</surname><given-names>LM</given-names></name></person-group><article-title>Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes</article-title><source>Proc Natl Acad Sci U S A</source><year>1993</year><volume>90</volume><issue>16</issue><fpage>7568</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.16.7568</pub-id><pub-id pub-id-type="pmid">8356058</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>YS</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Okamoto</surname><given-names>M</given-names></name><name><surname>Fujii</surname><given-names>M</given-names></name><name><surname>Fukutomi</surname><given-names>R</given-names></name><name><surname>Hori</surname><given-names>M</given-names></name><etal/></person-group><article-title>Centrosomal localization of RhoGDI&#x003b2; and its relevance to mitotic processes in cancer cells</article-title><source>Int J Oncol</source><year>2013</year><volume>42</volume><issue>2</issue><fpage>460</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">23232495</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leffers</surname><given-names>H</given-names></name><name><surname>Nielsen</surname><given-names>MS</given-names></name><name><surname>Andersen</surname><given-names>AH</given-names></name><name><surname>Honore</surname><given-names>B</given-names></name><name><surname>Madsen</surname><given-names>P</given-names></name><name><surname>Vandekerckhove</surname><given-names>J</given-names></name><etal/></person-group><article-title>Identification of two human Rho GDP dissociation inhibitor proteins whose overexpression leads to disruption of the actin cytoskeleton</article-title><source>Exp Cell Res</source><year>1993</year><volume>209</volume><issue>2</issue><fpage>165</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1006/excr.1993.1298</pub-id><pub-id pub-id-type="pmid">8262133</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theodorescu</surname><given-names>D</given-names></name><name><surname>Sapinoso</surname><given-names>LM</given-names></name><name><surname>Conaway</surname><given-names>MR</given-names></name><name><surname>Oxford</surname><given-names>G</given-names></name><name><surname>Hampton</surname><given-names>GM</given-names></name><name><surname>Frierson</surname><given-names>HF</given-names><suffix>Jr</suffix></name></person-group><article-title>Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer</article-title><source>Clin Cancer Res</source><year>2004</year><volume>10</volume><issue>11</issue><fpage>3800</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-03-0653</pub-id><pub-id pub-id-type="pmid">15173088</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griner</surname><given-names>EM</given-names></name><name><surname>Theodorescu</surname><given-names>D</given-names></name></person-group><article-title>The faces and friends of RhoGDI2</article-title><source>Cancer Metastasis Rev</source><year>2012</year><volume>31</volume><issue>3&#x02013;4</issue><fpage>519</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1007/s10555-012-9376-6</pub-id><pub-id pub-id-type="pmid">22718398</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Takegami</surname><given-names>T</given-names></name><name><surname>Suto</surname><given-names>S</given-names></name><name><surname>Tatsuka</surname><given-names>M</given-names></name></person-group><article-title>Activation of Rac1 by Rho-guanine nucleotide dissociation inhibitor-&#x003b2; with defective isoprenyl-binding pocket</article-title><source>Cell Biol Int</source><year>2007</year><volume>31</volume><issue>1</issue><fpage>92</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.cellbi.2006.09.002</pub-id><pub-id pub-id-type="pmid">17049467</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Suto</surname><given-names>S</given-names></name><name><surname>Tatsuka</surname><given-names>M</given-names></name></person-group><article-title>LyGDI functions in cancer metastasis by anchoring Rho proteins to the cell membrane</article-title><source>Mol Carcinog</source><year>2004</year><volume>39</volume><issue>4</issue><fpage>206</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1002/mc.20006</pub-id><pub-id pub-id-type="pmid">15057873</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Sakita-Suto</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Murakami</surname><given-names>M</given-names></name><name><surname>Takegami</surname><given-names>T</given-names></name><etal/></person-group><article-title>RhoGDI&#x003b2; lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed cells</article-title><source>Clin Exp Metastasis</source><year>2006</year><volume>23</volume><issue>7&#x02013;8</issue><fpage>323</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">17111235</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behar</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name></person-group><article-title>Understanding the temporal codes of intra-cellular signals</article-title><source>Curr Opin Genet Dev</source><year>2010</year><volume>20</volume><issue>6</issue><fpage>684</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2010.09.007</pub-id><pub-id pub-id-type="pmid">20956081</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>CJ</given-names></name></person-group><article-title>Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation</article-title><source>Cell</source><year>1995</year><volume>80</volume><issue>2</issue><fpage>179</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(95)90401-8</pub-id><pub-id pub-id-type="pmid">7834738</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitano</surname><given-names>H</given-names></name><name><surname>Funahashi</surname><given-names>A</given-names></name><name><surname>Matsuoka</surname><given-names>Y</given-names></name><name><surname>Oda</surname><given-names>K</given-names></name></person-group><article-title>Using process diagrams for the graphical representation of biological networks</article-title><source>Nat Biotechnol</source><year>2005</year><volume>23</volume><issue>8</issue><fpage>961</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1038/nbt1111</pub-id><pub-id pub-id-type="pmid">16082367</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldridge</surname><given-names>BB</given-names></name><name><surname>Burke</surname><given-names>JM</given-names></name><name><surname>Lauffenburger</surname><given-names>DA</given-names></name><name><surname>Sorger</surname><given-names>PK</given-names></name></person-group><article-title>Physicochemical modelling of cell signalling pathways</article-title><source>Nat Cell Biol</source><year>2006</year><volume>8</volume><issue>11</issue><fpage>1195</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1038/ncb1497</pub-id><pub-id pub-id-type="pmid">17060902</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>T</given-names></name><name><surname>Maeda</surname><given-names>M</given-names></name><name><surname>Odashima</surname><given-names>S</given-names></name></person-group><article-title>Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells</article-title><source>J Pharm Sci</source><year>1991</year><volume>80</volume><issue>12</issue><fpage>1141</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1002/jps.2600801210</pub-id><pub-id pub-id-type="pmid">1815072</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aoki</surname><given-names>K</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>T</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name></person-group><article-title>An essential role for the SHIP2-dependent negative feedback loop in neuritogenesis of nerve growth factor-stimulated PC12 cells</article-title><source>J Cell Biol</source><year>2007</year><volume>177</volume><issue>5</issue><fpage>817</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1083/jcb.200609017</pub-id><pub-id pub-id-type="pmid">17535963</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>TH</given-names></name><name><surname>Bohl</surname><given-names>BP</given-names></name><name><surname>Bokoch</surname><given-names>GM</given-names></name></person-group><article-title>Biologically active lipids are regulators of Rac. GDI complexation</article-title><source>J Biol Chem</source><year>1993</year><volume>268</volume><issue>35</issue><fpage>26206</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">8253741</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>R</given-names></name><name><surname>Weyand</surname><given-names>M</given-names></name><name><surname>Lammers</surname><given-names>M</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Ahmadian</surname><given-names>MR</given-names></name><name><surname>Wittinghofer</surname><given-names>A</given-names></name></person-group><article-title>Structural and mechanistic insights into the interaction between Rho and mammalian Dia</article-title><source>Nature</source><year>2005</year><volume>435</volume><issue>7041</issue><fpage>513</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nature03604</pub-id><pub-id pub-id-type="pmid">15864301</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name></person-group><article-title>The role of Mg<sup>2+</sup> cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><issue>33</issue><fpage>25299</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1074/jbc.M001027200</pub-id><pub-id pub-id-type="pmid">10843989</pub-id></element-citation></ref></ref-list></back></article>